Nektar Therapeutics (NASDAQ:NKTR)
| 0.6037 Delayed Data As of Jun 05 |  -0.0093 / -1.50%Today’s Change | 0.58 Today|||52-Week Range 5.18 | -73.29% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Zalevsky Jonathan Chief Research & Development Officer |  Sale | 8/18/2022 | 73,716 | $4.65 | $342.8K | -86.97% |
Robin Howard W President & Chief Executive Officer | Sale | 11/16/2022 | 38,014 | $3.57 | $135.7K | -82.67% |
Eastham Karin Director | Sale | 9/13/2022 | 21,267 | $3.61 | $76.8K | -82.82% |
Robin Howard W President & Chief Executive Officer | Sale | 8/16/2022 | 13,759 | $4.76 | $65.5K | -86.97% |
Robin Howard W President & Chief Executive Officer | Sale | 2/16/2023 | 19,635 | $3.00 | $58.9K | -79.53% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 8/16/2022 | 10,560 | $4.76 | $50.3K | -86.97% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 11/16/2022 | 13,460 | $3.57 | $48.1K | -82.67% |
Thomsen Jillian B Chief Financial Officer | Sale | 11/16/2022 | 11,095 | $3.57 | $39.6K | -82.67% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 2/16/2023 | 10,484 | $3.00 | $31.5K | -79.53% |
Wilson Mark A /nextkar/ Chief Legal Officer | Sale | 11/16/2022 | 8,690 | $3.57 | $31.0K | -82.67% |
Page of 4